These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 26607904)

  • 41. Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
    Oh CJ; Ha CM; Choi YK; Park S; Choe MS; Jeoung NH; Huh YH; Kim HJ; Kweon HS; Lee JM; Lee SJ; Jeon JH; Harris RA; Park KG; Lee IK
    Kidney Int; 2017 Apr; 91(4):880-895. PubMed ID: 28040265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.
    Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM
    Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo.
    Yuan SY; Cheng CL; Ho HC; Wang SS; Chiu KY; Su CK; Ou YC; Lin CC
    Eur J Pharmacol; 2015 Aug; 761():309-20. PubMed ID: 26086857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma.
    Li C; Meng G; Su L; Chen A; Xia M; Xu C; Yu D; Jiang A; Wei J
    Oncotarget; 2015 Jan; 6(3):1544-55. PubMed ID: 25575816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypoxia enhances antitumor activity of dichloroacetate.
    Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
    Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer.
    Wang PW; Abedini MR; Yang LX; Ding AA; Figeys D; Chang JY; Tsang BK; Shieh DB
    Int J Cancer; 2014 Dec; 135(12):2760-9. PubMed ID: 24771612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.
    Xue X; You S; Zhang Q; Wu Y; Zou GZ; Wang PC; Zhao YL; Xu Y; Jia L; Zhang X; Liang XJ
    Mol Pharm; 2012 Mar; 9(3):634-44. PubMed ID: 22289032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.
    Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z
    Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.
    Ito E; Yip KW; Katz D; Fonseca SB; Hedley DW; Chow S; Xu GW; Wood TE; Bastianutto C; Schimmer AD; Kelley SO; Liu FF
    Mol Pharmacol; 2009 Nov; 76(5):969-83. PubMed ID: 19654225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.
    Dhar S; Lippard SJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22199-204. PubMed ID: 20007777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.
    Sutendra G; Dromparis P; Kinnaird A; Stenson TH; Haromy A; Parker JM; McMurtry MS; Michelakis ED
    Oncogene; 2013 Mar; 32(13):1638-50. PubMed ID: 22614004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.
    Bonnet S; Archer SL; Allalunis-Turner J; Haromy A; Beaulieu C; Thompson R; Lee CT; Lopaschuk GD; Puttagunta L; Bonnet S; Harry G; Hashimoto K; Porter CJ; Andrade MA; Thebaud B; Michelakis ED
    Cancer Cell; 2007 Jan; 11(1):37-51. PubMed ID: 17222789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.
    Ji T; Gong D; Han Z; Wei X; Yan Y; Ye F; Ding W; Wang J; Xia X; Li F; Hu W; Lu Y; Wang S; Zhou J; Ma D; Gao Q
    Cancer Lett; 2013 Dec; 341(2):231-9. PubMed ID: 23962558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S; Ng CP; Bonavida B
    Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
    Nikravesh H; Khodayar MJ; Behmanesh B; Mahdavinia M; Teimoori A; Alboghobeish S; Zeidooni L
    BMC Cancer; 2021 Aug; 21(1):903. PubMed ID: 34364387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma.
    Lu H; Lu Y; Xie Y; Qiu S; Li X; Fan Z
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity.
    Trapella C; Voltan R; Melloni E; Tisato V; Celeghini C; Bianco S; Fantinati A; Salvadori S; Guerrini R; Secchiero P; Zauli G
    J Med Chem; 2016 Jan; 59(1):147-56. PubMed ID: 26653539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.